Currently, there are three categories of mainstream approaches for KRAS mutation detection in cancer samples, such as DNA sequencing (Sanger sequencing and high throughput paralleled sequencing), fluorescent probe-based real-time PCR (TaqMan probe, molecular beacon, etc.), and droplet digital PCR (ddPCR). The gene discussed is KRAS; the disease is cancer.